The clinical use of automated implantable cardioverter defibrillators (AICDs) has been rapidly increasing since the results of several randomized trials confirmed the efficacy of AICDs in the secondary and primary prevention of sudden cardiac death. Patients with AICDs require high-quality care and intense follow-up to ensure safe and effective device performance. According to international guidelines these patients should be followed at 1- to 4 month intervals, depending on the device model and the patient’s clinical status (Schoenfeld, 2004). Given the expanding indications for use and the complexity of these devices, there is an urgent need to develop new means of ICD follow-up, so as to optimize patient safety and the use of healthcare resources. An internet-based remote-monitoring system could provide a practical substitute to time-consuming and expensive in-office visits. Although the initial experience with these systems has been favorable, many practical issues remain. In particular, more information is required on the usability and safety of remote monitoring for patient-initiated transmissions and cost effectiveness of the system as a substitute for routine in-office visits during long-term follow-up.
Recommended CitationShirato, MSN, RN, CCRN, Susan, "The Use of Remote Monitoring for Internal Cardioverter Defibrillators (ICDS): The Infusion of Information Technology and Medicine" (2009). College of Nursing Faculty Papers & Presentations. Paper 23.